Induction of immune tolerance and suppression of anaphylaxis in a child with haemophilia B by simple plasmapheresis and antigen exposure

Haemophilia

Volumn 6, Issue 6, 2000, Pages 693-695

  Barnes, C ^a,b   Rudzki, Z ^a,b   Ekert, H ^a,b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

Anaphylaxis; Antigen exposure; Factor IX inhibitor; Immune tolerance; Plasmapheresis

Indexed keywords

ADRENALIN; ANTIGEN; ANTIHISTAMINIC AGENT; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 9; BLOOD CLOTTING FACTOR 9 CONCENTRATE; CORTICOSTEROID; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MIDAZOLAM; MONOFIX; MORPHINE; PROTHROMBIN COMPLEX; PROTHROMBINEX HT;

ANAPHYLAXIS; ARTICLE; CASE REPORT; DRUG INFUSION; DYSPNEA; FLUSHING; FOLLOW UP; FRAMESHIFT MUTATION; HEMARTHROSIS; HEMOPHILIA B; HUMAN; HYPOTENSION; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; INFANT; MALE; PLASMAPHERESIS; PRIORITY JOURNAL; STEROID THERAPY; SUBSTITUTION THERAPY; TACHYCARDIA; TREATMENT OUTCOME; WHEEZING;

ANAPHYLAXIS; ANTIGENS; FACTOR IX; HEMOPHILIA B; HUMANS; IMMUNE TOLERANCE; INFANT; MALE; PLASMAPHERESIS;

EID: 0033675683     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.2000.00419.x     Document Type: Article

References (7)

1. Biology of factor IX
2. Molecular biology of haemophilia B
3. Factor IX inhibitors in haemophilia B patients: Their incidence and prospects for development with high purity factor IX products
4. Factor IX inhibitors anaphylaxis haemophilia
5. Factor IX inhibitors in patients with haemophilia B survey results form 82 treatment centres in the United States and Canada
6. Management of haemophilia B patients with inhibitors and anaphylaxis
7. Induction of Immune tolerance in patients with haemophilia and antibodies to factor VII by combined treatment with intravenous IgG, cyclophosphamide and factor VIII